Cargando…
The Therapeutic Potential of Galectin-3 in the Treatment of Intrahepatic Cholangiocarcinoma Patients and Those Compromised With COVID-19
The novel coronavirus pneumonia COVID-19 is characterized by all age susceptibility, which imposes a dramatic threat to the human species all over the world. According to current available data, the cytokine storm appears to be the most life-threatening symptom of severe COVID-19 cases accompanied w...
Autores principales: | Li, Hao, Li, Jianmin, Xiao, Wei, Zhang, Yujing, Lv, Yuan, Yu, Xing, Zheng, Jiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180910/ https://www.ncbi.nlm.nih.gov/pubmed/34109213 http://dx.doi.org/10.3389/fmolb.2021.666054 |
Ejemplares similares
-
A Myeloid Signature-Based Nomogram Predicts the Postoperative Recurrence of Intrahepatic Cholangiocarcinoma
por: Liang, Jing, et al.
Publicado: (2021) -
AMPK as a Potential Therapeutic Target for Intervertebral Disc Degeneration
por: Wang, Zhen, et al.
Publicado: (2021) -
An Automated Approach to Assess Relative Galectin-Glycan Affinity Following Glycan Microarray Analysis
por: Ho, Alex D., et al.
Publicado: (2022) -
Adverse events after the transjugular intrahepatic portal shunt are linked to serum metabolomic changes following the procedure
por: Chen, Quan, et al.
Publicado: (2023) -
Dynamic changes of metabolic characteristics in neonatal intrahepatic cholestasis caused by citrin deficiency
por: Zhang, Ting, et al.
Publicado: (2022)